Podcasts about Sibley Memorial Hospital

CancerNetwork® visited Sibley Memorial Hospital of Johns Hopkins Medicine to speak with a variety of experts about therapeutic advancements and ongoing research initiatives across several different cancer fields. As part of each discussion, clinicians highlighted how collaboration across different departments has positively impacted treatment planning, decision-making, and outcomes at their institution. These experts included the following: ·      Rachit Kumar, MD, an assistant professor of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins School of Medicine and a radiation oncologist specializing in genitourinary and gastrointestinal cancers at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center for Sibley Memorial Hospital and Suburban Hospital; ·      Michael J. Pishvaian, MD, PhD, director of Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs, and associate professor of Oncology at Johns Hopkins School of Medicine; ·      Nina Wagner-Johnston, MD, a professor of Oncology and the director of Lymphoma Drug Development at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, director of Hematologic Malignancies National Capital Region, and co-director of Clinical Research for Hematologic Malignancies; ·      Valerie Lee, MD, an assistant professor of Oncology at Johns Hopkins University School of Medicine and a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital; ·      Armine Smith, MD, the director of urologic oncology at the Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital, and an assistant clinical professor of Urology at the Brady Urological Institute of Johns Hopkins University School of Medicine; ·      Pouneh Razavi, MD, the director for Breast Imaging in the National Capital Region and an instructor in Radiology and Radiological Science; ·      and Curtiland Deville Jr., MD, medical director of the Johns Hopkins Proton Therapy Center and clinical director of Radiation Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital. Altogether, their insights demonstrated how multidisciplinary teamwork has improved outcomes ranging from patient survival to healthcare resource utilization across a wide range of diseases including breast cancer, gastrointestinal cancer, genitourinary cancer, hematologic malignancies, and others.

In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Nina Wagner-Johnston about the treatment of lymphoma and the newly opened Cellular Therapy Program at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC.  Lymphoma is a blood cancer of the immune system. There are many types of lymphomas with a broad range of aggressiveness and clinical behaviors but they are also among the most treatable. Learn more about the different types of lymphomas here. The Cellular Therapy Program at Sibley Memorial Hospital makes bone marrow transplants more readily available in the Washington DC region allowing patients to remain closer to home while receiving treatment.

In this episode of Bladder Cancer Matters, host Rick Bangs speaks with Dr. Armine Smith, Director of Urologic Oncology at Sibley Memorial Hospital and a leading expert in bladder cancer. They dive deep into the significant disparities in bladder cancer diagnosis and outcomes between men and women, exploring the biological, socioeconomic, and healthcare-related factors behind these differences. Dr. Smith highlights the urgent need for better awareness, timely diagnosis, and gender-sensitive treatment options, including exciting new research into the role of the microbiome and sex hormones in bladder cancer progression. With her passion and expertise, Dr. Smith offers actionable insights for both patients and healthcare providers. Tune in to learn about these critical issues and how we can collectively work to improve bladder cancer care for women.

Every woman will eventually go through menopause and while each woman's experience is unique, there is some unique experiences that unite women of color during perimenopause through post-menopause.  Special guest moderator for this podcast is psychiatrist Erica Richards, who serves as Chair and Medical Director in the Department of Psychiatry and Behavioral Health at Sibley Memorial Hospital.  Dr. Richards sits down to discuss what women of color need to know about menopause with associate professor of gynecology and obstetrics, Dr. Wen Shen, who serves as director of the Women's Wellness & Healthy Aging Program at Johns Hopkins.

In this enlightening episode of our podcast, we sit down with renowned lactation specialist, Amy Tanzillo, to delve into the common and often unspoken challenges of breastfeeding. Amy brings her extensive knowledge and compassionate approach to discuss issues that often accompany breastfeeding. She also provides practical advice tips for breastfeeding mothers and strategies for balancing breastfeeding with returning to work. Whether you're a new mother facing these challenges or just interested in understanding the breastfeeding journey, this episode offers valuable insights and supportive guidance. Join us for an informative session with Amy Tanzillo, where we uncover the complexities and triumphs of breastfeeding. About Amy Tanzillo (in her words) When I was in your shoes, I didn't do anything to prepare myself for breastfeeding. I may have taken an overview at the hospital, but I had no idea what it was like to breastfeed my baby. It didn't even cross my mind that breastfeeding could be really hard, or painful or the 50 other reasons my clients reach out to me. It was when I was expecting my third, I decided to become an International Board Certified Lactation Consultant (IBCLC). To say knowledge is power is the understatement of the century. What I learned in the countless courses and 500 clinical hours at Sibley Memorial Hospital, completely changed how I navigated breastfeeding. I'll admit I feel a little robbed that I didn't know as much about breastfeeding my firstborn and daughter.  For the sake of sanity, I believe that timing is everything and it all worked out. With that being said, if I can help expectant and new moms feel as confident and empowered about breastfeeding as I did with my third, then it's worth making supporting you my life's work! So, I get it. I don't only get it but I'm here to be your designated support person along the way. I help navigate breastfeeding issues before they become problems with personalized support and a customized plan. Learn more from Amy at: https://thrivebreastfeeding.com/ About Theresa Inman A wife and a mother to two children and grandmother, Theresa Alexander Inman is a Parenting Coach, Board Certified Behavior Analyst, and Infant Toddler Development Specialist. She was introduced to the field of behavior analysis in 2007 after working in many capacities in the juvenile justice system. Her goal is to improve the lives of children and families by helping them strategize child develop skills to prevent or reduce the effects of possible delays while having fun! Theresa is also an author, having published ⁠⁠⁠⁠⁠⁠⁠⁠⁠“How Can I Help My Child Communicate?”⁠⁠⁠⁠⁠⁠⁠⁠⁠ in 2022. Connect with Theresa today! • Instagram | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Theresa Inman⁠⁠⁠⁠⁠⁠⁠⁠⁠ • LinkedIn | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Theresa Inman⁠⁠⁠⁠⁠⁠⁠⁠⁠ • BabyBoomer.org | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Theresa Inman⁠⁠⁠⁠⁠⁠⁠⁠⁠ • YouTube | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Parenting with Confidence⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Tiktok | ⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.tiktok.com/@parentcoachtheresa • Spotify via Anchor.fm | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Parenting with Confidence ⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website: https://www.theresaalexanderinman.com/ Executive Contributor at Brains Magazine l ⁠⁠⁠⁠⁠⁠Read more from Theresa!⁠⁠⁠⁠⁠⁠ About Parenting with Confidence Parenting with Confidence with Theresa Alexander Inman presents you with answers if you are a tired and frustrated parent with a child diagnosed with a developmental delay. We aim to lift you up from the pressure of doing it right and provide you with the resources to set you and your child up for success! Please comment, share and download --- Send in a voice message: https://podcasters.spotify.com/pod/show/theresa-alexander-inman/message Support this podcast: https://podcasters.spotify.com/pod/show/theresa-alexander-inman/support

About This EpisodeCarolyn Carpenter defines boldness as going beyond our limiting dimensions. She encourages us to push back against self-imposed boundaries and open ourselves to the possibilities that life offers. As President of Johns Hopkins National Capital Region and a mother of two, she discusses how this boldness manifests in both our personal and professional journeys. Carolyn encourages us to not allow the limitations we put on ourselves to restrict our potential to live authentically. It's not only about managing our energy, but about letting go of fear and anxiety and embracing optimism as well. Carolyn also describes how to recognize patterns of opportunity and tap into our creative intelligence.  About Carolyn CarpenterCarolyn Carpenter serves as President of Johns Hopkins National Capital Region (NCR), where she leads all hospital-based and community-based ambulatory sites across the National Capital Region on behalf of Johns Hopkins Medicine (JHM), including Sibley Memorial Hospital and Suburban Hospital. Prior to joining Johns Hopkins, Ms. Carpenter served as the President of Sentara Norfolk General Hospital and Corporate Vice President of Sentara Healthcare. Ms. Carpenter joined Sentara after twenty years of progressive leadership responsibility at Duke Health. During that time, she served in a variety of capacities including Chief Operating Officer of 900+-bed Duke University Hospital, Associate Dean of the Duke School of Medicine, Associate Vice President of Oncology Services for the Duke Health System, and Associate Chief Operating Officer for Medical/Surgical/Critical Care Services. Ms. Carpenter received her B.A. at the University of Pennsylvania and her MHA from Medical College of Virginia. She completed an administrative fellowship at Duke. She is a Fellow of the American College of Healthcare Executives and was an Adjunct Assistant Professor at the University of North Carolina at Chapel Hill School of Public Health. In 2016-7, Ms. Carpenter was among the inaugural class of Carol Emmott Fellows, a select fellowship for women leaders aimed at empowering female health executives to bridge the gender gap in the C-suite and transform health care. Additional ResourcesLinkedIn: @CarolynCarpenter

October is Breast Cancer Awareness Month. In recognition of Breast Cancer Awareness Month, podcast moderator Lillie Shockney is joined breast surgeon Dr. Hanh-Tam Tran, clinical associate at the Sullivan Breast Center at the Sibley Memorial Hospital, whose clinical research focuses on identifying patients who could avoid having axillary surgery to discuss ductal carcinoma In Situ (DCIS) breast cancer, which accounts for about 20% of breast cancers.  

Motherhood is a remarkable journey, woven with threads of joy, challenges, and transformation. In this enlightening episode, we step into the world of new moms, guided by Amy Tanzillo, an expert who has witnessed their incredible transformations. Join us as we explore the transformative journey of these mothers – from the depths of feeling overwhelmed to the heights of embracing confident breastfeeding. About Amy (in her words) When I was in your shoes, I didn't do anything to prepare myself for breastfeeding. I may have taken an overview at the hospital, but I had no idea what it was like to breastfeed my baby. It didn't even cross my mind that breastfeeding could be really hard, or painful or the 50 other reasons my clients reach out to me. It was when I was expecting my third, I decided to become an International Board Certified Lactation Consultant (IBCLC). To say knowledge is power is the understatement of the century. What I learned in the countless courses and 500 clinical hours at Sibley Memorial Hospital, completely changed how I navigated breastfeeding. I'll admit I feel a little robbed that I didn't know as much breastfeeding my firstborn and daughter.  For the sake of sanity, I believe that timing is everything and it all worked out. With that being said, if I can help expectant and new moms feel as confident and empowered about breastfeeding as I did with my third, then it's worth making supporting you my life's work! So, I get it. I don't only get it but I'm here to be your designated support person along the way. I help navigate breastfeeding issues before they become problems with personalized support and a customized plan. Learn more from Amy at: https://thrivebreastfeeding.com/ Connect with her on social media: @thrivebreastfeeding Amy also highly recommends this couple's coach for those who are interested in such services: https://instagram.com/strongerparenthood?igshid=NzZhOTFlYzFmZQ== About Theresa Inman A wife and a mother to two children and grandmother, Theresa Alexander Inman is a Parenting Coach, Board Certified Behavior Analyst, and Infant Toddler Development Specialist. She was introduced to the field of behavior analysis in 2007 after working in many capacities in the juvenile justice system. Her goal is to improve the lives of children and families by helping them strategize child develop skills to prevent or reduce the effects of possible delays while having fun! Theresa is also an author, having published ⁠⁠⁠⁠⁠⁠⁠⁠⁠“How Can I Help My Child Communicate?”⁠⁠⁠⁠⁠⁠⁠⁠⁠ in 2022. Connect with Theresa today! • Instagram | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Theresa Inman⁠⁠⁠⁠⁠⁠⁠⁠⁠ • LinkedIn | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Theresa Inman⁠⁠⁠⁠⁠⁠⁠⁠⁠ • BabyBoomer.org | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Theresa Inman⁠⁠⁠⁠⁠⁠⁠⁠⁠ • YouTube | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Parenting with Confidence⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Tiktok | ⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.tiktok.com/@parentcoachtheresa • Spotify via Anchor.fm | ⁠⁠⁠⁠⁠⁠⁠⁠⁠Parenting with Confidence ⁠⁠⁠⁠⁠⁠⁠⁠⁠ About Parenting with Confidence Parenting with Confidence with Theresa Alexander Inman presents you with answers if you are a tired and frustrated parent with a child diagnosed with a developmental delay. We aim to lift you up from the pressure of doing it right and provide you with the resources to set you and your child up for success! --- Send in a voice message: https://podcasters.spotify.com/pod/show/theresa-alexander-inman/message Support this podcast: https://podcasters.spotify.com/pod/show/theresa-alexander-inman/support

Dr Ashwani Rajput talks with Dr Solmaz Sahebjam about the treatment of tumors in the brain and along the spine.

Dr Ashwani Rajput talks with Dr Khaled El-Shami about the diagnosis, treatment, and care for patients with leukemias, lymphomas, and myelomas.

Dr. Erica Richards, Chair and Medical Director of the Department of Psychiatry at Sibley Memorial Hospital joins us to discuss the nuances of women's mental health. We discuss underrepresented groups, stigmas, and everyday challenges that often prevent people from seeking help. Dr. Richards also explains how the pandemic has taught us new ways to treat depression and anxiety. Join us for this eye-opening conversation.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aline Charabaty, MD Given what medications are currently available, inflammatory bowel disease (IBD) can be difficult to manage. What do we need to know about them, and how do we know which of our patients are the right candidates for them? To answer this question, Dr. Peter Buch speaks with Dr. Aline Charabaty from the Sibley Memorial Hospital.

Dr Ashwani Rajput speaks with Dr Karim Boudadi about treating head and neck cancers, including HPV-related cancers.

Dr Ashwani Rajput talks with Dr Ben Levy from Sibley Memorial Hospital about the results of the Checkmate-816 clinical trial, which is leading to major changes in the way patients with non-small cell lung cancer are being treated. Click here to learn more about the Checkmate-816 trial.

Dr Bill Nelson speaks with Dr Channing Paller from the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC and Dr Heather Cheng from the Fred Hutchinson Cancer Research Center about the PROMISE prostate cancer registry. The PROMISE registry is studying the role of genetics in determining health outcomes for patients with prostate cancer. Learn more about PROMISE at prostatecancerpromise.org/

Supreme Court Justice Clarence Thomas has been hospitalized since Friday due to an infection, the high court said Sunday. The 73-year-old was admitted into Sibley Memorial Hospital in Washington, DC after experiencing “flu-like symptoms,” the court said. The court did not elaborate on the type of infection Thomas was suffering from or explain the two-day delay in announcing the hospitalization. It was revealed by the high court, however, that Thomas was being treated with antibiotics and is on the mend. The court said the justice could be sent home in the coming days. Arguments in four cases will be heard by the Supreme Court this week. Thomas, who has been on the court since 1991, plans to take part in the cases even if he's absent for the arguments, the court said. --- Support this podcast: https://anchor.fm/mike-k-cohen/support

Season 2 Episode 7- Charita Marthone, PharmD, BCOPOn today's episode of The PQI Podcast we welcome Charita Marthone, PharmD, BCOP. Charita is a Clinical Oncology Specialist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, DC.Today we discuss her role as a Clinical Oncology Specialist and the development of Sibley Memorial Hospital's clinical pharmacy program, telehealth and financial toxicity of oral chemotherapy treatment.

Dr Akila Viswanathan and Dr Aditya Halthore discuss the treatment of patients with lung and genitourinary cancers at the Johns Hopkins Proton Therapy Center located at Sibley Memorial Hospital in Washington DC.

Join Grant McGaugh on the release of Follow the Brand's 3rd episode in Season 1. In this chapter, Grant sits down with Deborah Lee Eddie an accomplished and gracious professional who shares wisdom on personal branding, executive coaching, and much more.BIODeborah Lee-Eddie, FACHE, has more than a quarter-century of progressively responsible leadership roles at the facility, market and system level in faith-based, nonprofit, public, and academic medical centers. Her background includes experience in both health plans and acute-care delivery. Lee-Eddie served for eight years at Englewood, Colo.-based Catholic Health Initiatives as one of five senior vice presidents of operations, reporting to the system chief operating officer. Now focused on interim management and consulting, Lee-Eddie has served in key leadership roles at several large health systems, including interim executive positions with Sibley Memorial Hospital in Washington, D.C., and Crozer-Chester Medical Center in Philadelphia. Other professional positions included chief administrative officer of the Children's Hospital at Jackson Memorial Health System in Miami; CEO of Brackenridge Hospital in Austin, Texas; and vice president of Erlanger Medical Center in Chattanooga, Tenn.  A former president of the National Association of Health Services Executives and a past member of the University of Michigan School of Public Health Dean's Advisory Board, Lee-Eddie also served as a member of the Board of Overseers and as a national judge for the Malcom Baldridge National Quality Award. She is a fellow in the American College of Healthcare Executives and Co-Founder of the NAHSE South Florida ChapterFollow The Brand is produced by 5 STAR BDM.  Contact us for a quote on Podcast Productions.Tags: branding,brand-development,self-branding,podcasting,podcast,confidence,podcaster

Forest therapy is inspired by the Japanese practice of shinrin-yoku, which translates to “forest bathing.” Studies have demonstrated a wide array of health benefits, especially in the cardiovascular and immune systems, and for stabilizing and improving mood and cognition. Today, we talk about forest bathing and nature therapy, or ecotherapy, with Harpreet Gujral, DNP FNP-BC, program director and nurse practitioner, Sibley Integrative Medicine, Sibley Memorial Hospital, Johns Hopkins Health System. Dr. Gujral is an integrative nurse practitioner and director of the inpatient surgical unit at HCA Healthcare in Reston, Virginia. The hospital has a special interest in the resilience and wellbeing of frontline healthcare providers. She incorporates her training in conventional nursing with aromatherapy, guided imagery and various Eastern modalities like ayurveda, mindfulness, and meditation. These are therapies that are enhanced by her roots in India. ◘ Related Content The Science Behind Forest Therapy https://www.natureandforesttherapy.earth/about/the-science Association of Nature and Forest Therapy Guides and Programs https://www.natureandforesttherapy.earth/about/the-practice-of-forest-therapy Psychology Today: Nature Therapy https://www.psychologytoday.com/us/blog/evolutionary-psychiatry/201608/nature-therapy Healthline: Ecotherapy and the Healing Power of Nature https://www.healthline.com/health/mental-health/ecotherapy ◘ Transcript https://www.linkedin.com/pulse/transcript-forest-bathing-melding-mindfulness-nature-gw-office-of/?published=t ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

The community health design and innovation team at Sibley Memorial Hospital, a member of Johns Hopkins Medicine, invited communities in DC's Wards 7 & 8 to help define their own solutions to health disparities and inequities. The resulting Ward Infinity social innovation program is now a model for community intervention.

The community health design and innovation team at Sibley Memorial Hospital, a member of Johns Hopkins Medicine, invited communities in DC's Wards 7 & 8 to help define their own solutions to health disparities and inequities. The resulting Ward Infinity social innovation program is now a model for community intervention.

The community health design and innovation team at Sibley Memorial Hospital, a member of Johns Hopkins Medicine, invited communities in DC's Wards 7 & 8 to help define their own solutions to health disparities and inequities. The resulting Ward Infinity social innovation program is now a model for community intervention.

In this episode, we are privileged to host Dr. Veronica Vela, the Director of Community Health Design and Innovation at Sibley Memorial Hospital. Our conversation centered around improving community health and bringing the consumer into the decision-making process. Dr. Vela talks about the different programs she is involved in like Ward Infinity and Market Seven. She also shares anecdotes and amazing insights gained from her years of working in the Department of Veterans Affairs and with another government agency. This is an awesome interview, truly thought-provoking, and a must-listen for health leaders, so please tune in! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Dr. Sam Harrington joins us for conversation on his book, ‘At Peace: Choosing a Good Death After a Long Life.' Sam Harrington is an honors graduate of Harvard College and the University of Wisconsin Medical School, he practiced internal medicine and gastroenterology for more than 30 years in Washington, D.C. There he served on the board of trustees of Sibley Memorial Hospital, a member of the Johns Hopkins Health System, and the former Hospice Care of DC.

Dr Ashwani Rajput, the Director of the Johns Hopkins Kimmel Cancer Center in the National Capital Region, begins his podcast series speaking with Dr Ben Levy from Sibley Memorial Hospital about the treatment of lung cancer and the cancer services available through the Kimmel Cancer Center in the Greater Washington DC Area.

In a broad discussion, Dr Otis Brawley and Dr Curtiland Deville from Sibley Memorial Hospital discuss the range of available treatments for prostate cancer, reducing cancer disparities, and increasing minority representation in radiation oncology.

Dr. Colette M. Magnant is a board certified breast surgeon at Sibley Memorial Hospital. She is the chair of the Sibley Cancer Committee and the director of the Sullivan Breast Center, of which she is also the founding physician. Dr. Magnant talks about her interest in pursuing a medical career, her observations on developments in the treatment of breast cancer and her dedication to starting a Women’s Health Center at Sibley, the only resource of its kind in the country, that would offer all aspects of women’s health services in one facility on the Sibley Memorial campus.  

July 7, 2020 A procurement discussion on forthcoming Indefinite-Delivery Indefinite-Quantity (IDIQ) contracts, purchasing collectives, and the DC Community Anchor Partnership (DCAP). Guest Speakers: Steve Glaude-President & CEO of Coalition for Nonprofit Housing & Economic Development (CNHED) Marissa McKeever- Director of Government and Community Affairs at Sibley Memorial Hospital at John Hopkins Medicine Shinar Little-Local business that has participated in DCAP Contributors: Sybongile Cook, Director of Business Development, Office of the Deputy Mayor for Planning and Economic Development George Schutter, Chief Procurement Officer, DC Office of Contracting and Procurement Jay Melder, Assistant City Administrator Milton Goodman, Manager, DSLBD's DC Procurement Technical Assistance Center (PTAC) Video: https://www.youtube.com/watch?v=Np-lGqFAI7o Presentation: https://drive.google.com/file/d/1AM7Go1iwMP0TYY8CFUADgPKH6U2MiQPN/view?usp=sharing --- For more info, visit https://coronavirus.dc.gov/recovery-business Connect with Mayor Bowser on Social Media: Follow Mayor Bowser on Facebook: http://bit.ly/2mnwZmZ Follow Mayor Bowser on Twitter: http://bit.ly/2mlFrD8 Follow Mayor Bowser on Instagram: http://bit.ly/2mfkKIP

An interview with Dr. Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital on “Lung Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.” This guideline provides recommendations to clinicians on radiographic imaging and biomarker surveillance strategies after definitive curative-intent therapy in patients with stage I-III non–small-cell lung cancer and small-cell lung cancer. Read the full guideline at www.asco.org/thoracic-cancer-guidelines   Transcript Hi. My name is Clifford Hudis, and I am the CEO of the American Society of Clinical Oncology, as well as the host of the ASCO in Action podcast. About twice a month, I interview thought leaders in health care and experts in oncology, and we provide analysis and commentary on a wide range of cancer policy and practice issues. You can find the ASCO in Action podcast on Apple Podcasts or wherever you are listening to this show, and you can find all nine of ASCO's podcasts which cover a wide range of educational and scientific content, and offer enriching insight into the world of cancer care at podcast.asco.org.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Hello and welcome to the ASCO Guidelines podcast series, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content, and offering enriching insight into the world of cancer care. You can find all the shows, including this one, at podcast.asco.org. My name is Brittany Harvey, and today I'm interviewing Dr. Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, author on "Lung Surveillance After Definitive Curative Intent Therapy ASCO Guideline." Thank you for being here, Dr. Levy.   Thanks for having me.   So first, can you give us a general overview of what this guideline covers?   Yeah, I think that the general broad stroke intent of this consensus paper was to provide evidence-based guidelines and recommendations for practicing clinicians on what the optimal radiographic imaging and biomarker surveillance strategy should be for patients who received definitive curative intent therapy, and specifically for patients with stage I through III non-small-cell lung cancer, or patients who have received curative intent therapy for a limited-stage small-cell lung cancer.   And importantly, this expert panel comprised a multidisciplinary team, and this included not only medical oncologists, but surgical oncologists, pulmonologists, radiologists, a general internist, a patient representative. So we had, I think, the relevant stakeholders to make the best recommendations we could based on the evidence. And we really framed our recommendations by answering five questions, and I think we can get to the five questions at a later time during this cast, but we try to answer these five questions in a systematic way. And really looked at the type-- was an evidence-based or was it informal consensus? What was the evidence quality? Was it low, was it intermediate, or was it high? And then finally, the strength of the recommendation.   And importantly, we tried to answer these questions based on the evidence. We did a literature search, which culminated in a systematic review of more than-- close to 1,200 studies of which 14 studies were identified, and these 14 studies included meta-analysis, randomized control trials, case-controlled trials, and retrospective studies, and really by doing this, we wanted to come up with important guidelines. I think these guidelines are coming on the heels of a lot of confusion about what is the optimal surveillance strategies post-curative intent therapy for our lung cancer patients? So we recognize this confusion and tried our best to create guidelines that were reasonable to follow, and hopefully it can change practice.   Great. So you just mentioned that there were five key questions that you looked at for this guideline.   Yeah.   Could you elaborate on what those questions are and the key recommendations of the guideline?   Sure. So the crux of our recommendations, again, come on these five questions, and just a summary of these questions. One, what should be the frequency of surveillance imaging post-curative intent therapy? Two, what is the optimal imaging modality? Three, are there any patient factors such as performance status or age limits that would preclude surveillance? Four, is there a role for circulating biomarkers and surveillance? And then five, is there-- or what is the role of brain MRI imaging for surveillance of curative intent patients both non-small cell and small-cell?   And just briefly in terms of-- I'll maybe go over briefly just the answers to these questions that we tried to hash out in this consensus work-- for the question, what should be the frequency of surveillance imaging? We recommended that patients should undergo surveillance imaging for recurrence every six months for two years. We then recommend that patients should undergo surveillance imaging for detection of new primary lung cancers annually after the first two years.   And in question 2, what is the optimal imaging modality? We recommended a diagnostic chest CT that included the adrenals with contrast, that's preferred, or without contrast when conducting surveillance for recurrence during the first two years post-treatment. We did state that there was no evidence of any added benefit for CT of the abdomen and pelvis over a chest CT through the adrenals, that surveillance. We then, again, similar answer to recommendation 1, we do recommend a low dose screening for chest CT when conducting surveillance for new lung primaries after those first two years. And then I think importantly, we take a hard stand on PET scans as part of the answer to question 2, where we really should not be using PET scans as a surveillance tool in the surveillance starting post-curative intent therapy.   Question 3, are there any patient factors such as performance status or age limits that would preclude surveillance? And for us, we make the recommendation that surveillance imaging may be permitted in some patients who are clinically unsuitable, have multiple medical comorbidities, or unwilling to undergo further treatment. Doesn't make a lot of sense to offer surveillance imaging if patients are stating that they're not going to undergo any further treatment. We also state that age should not preclude surveillance imaging, but there needs to be a consideration for overall health status and chronic medical conditions and patient preferences.   Question 4 was, is there a role for circulating biomarkers in surveillance? And this is probably one of the more confusing parts of surveillance. Many physicians are still using CEA to monitor for a recurrence, and we really take a hard stand and say that clinicians should not be using circulating biomarkers as surveillance strategy for the detection of recurrence in patients who've undergone curative intent treatment, but we also do state that there is emerging data looking at ctDNA that may change this over the next four or five years, but we're certainly not there yet. So standard of care should not be-- to be using anything like that.   And then question 5 is, are there-- or what is the role for brain MRI for surveillance in patients with both non-small-cell and small-cell? And our recommendations are a little nuanced here. We did say for patients with stage I through III non-small-cell lung cancer, clinicians should not be using a brain MRI for routine surveillance after curative intent therapy, and patients who have undergone curative intent treatment for small-cell and did not receive prophylactic cranial radiation, this is where we do say clinicians should offer a brain MRI every three months for the first year and then every six months for the second year for surveillance. So a little bit different surveillance strategies for patients whether you're small-cell or non-small-cell.   So those are the broad stroke overviews of the recommendations that we put together in this consensus statement.   And then can you speak to the importance of this guideline and these recommendations and how they will impact practice?   I think that ASCO recognized how much confusion there was post-curative intent therapy. So I think this is the reason why these guidelines are so important. We need to keep in mind that health care resources that are utilized and be mindful of that. There's no real role for routine imaging less than the intervals that we're describing as they may obviously not be in touch with health care utilization and cost.   The other thing is this idea that patients are getting scans so frequently that we're picking up on a lot of false positive information that can't be used, and so we recognize that as well. So I think that on the heels of the confusion coupled with cost considerations, as well as what we're picking up on frequent scans, we do have to make recommendations that will hopefully unify and harmonize practice across the country to better suit patients and also evidence-based practice. I think that's really important.   And finally, how will these guideline recommendations affect patients?   Yeah, I think patients hopefully, if physicians follow these guidelines, will be receiving the appropriate interval. I mean, look, we understand that two-thirds of patients with lung cancer who relapse will present with metastatic disease and that there have been limited data thus far on what should be the optimal interval for scans. But we understand also that patients who do relapse could present with potentially curable lung cancer, and in addition, there's been recent data to suggest that even patients with limited metastatic disease who was detected on recurrence may be cured or may have improved survival with certain strategies like local ablative therapy.   So we hope that these guidelines can be firmly cemented into the practice for clinicians so that the appropriate interval is selected, but that also patients can benefit from these appropriately timed-out scans to improve outcomes for them.   Great. Thank you for your work on these guidelines, and thank you for taking the time today to give an overview to our listeners, Dr. Levy.   Thank you so much.   And thank you to all of our listeners for tuning into the ASCO Guidelines podcast series. To read the full guideline, go to www.asco.org/thoracic-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO guidelines app available on iTunes or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.

Dr Rosanne Sheinberg and Harpreet Gujral discuss the importance of a healing environment as well as some recent additions to Sibley Memorial Hospital that aid patients in their recovery process.

And on the FarrCast we help navigate the turmoil for you! This week Coronavirus is in the news and Asian markets are shaky. Michael begins with guest Dr. Nadia Eltaki, Director of Clinical Operation of the Emergency Department at Sibley Memorial Hospital. Dr. Eltaki walks us through what we know about Coronavirus, and the procedures in place to keep it under control if it comes to the US. We then talk with our resident China expert Dan Mahaffee on the impact on Chinese society, and special guest Douglas Steenland, who was President of Northwest Airlines during the SARS outbreak. In the third segment, Michael has a wide ranging discussion with Doug, who is now Chairman of the Board at AIG. He led the rescue team that took steered the company from its bailout to raising the cash to repay the government for the bailout in three years -- with interest. His insight into the current state of the economy is something you won't want to miss! It's the FarrCast: Wall Street, Washington, and The World.

Dr Bill Nelson speaks with Dr Christina Tsien, Medical Director of the new Johns Hopkins Proton Therapy Center at Sibley Memorial Hospital, about the science behind proton therapy.

The Johns Hopkins National Proton Therapy Center at Sibley Memorial Hospital opened its door the Fall of 2019.  Proton therapy is an advanced and highly precise radiation treatment for tumors and compared to other methods, focuses more energy on the tumor itself with less radiation to surrounding healthy tissue.  Proton beams can be used to treat: Sarcomas, particularly those in the base of the skull, spine or the retroperitoneum Breast cancer Prostate cancer Rhabdomyosarcoma, melanoma and other cancers around the eye Lung cancer and other thoracic cancers such as lymphoma or thymoma Head and neck cancer Liver cancer Pancreatic cancer Benign tumors Lillie Shockney interviews radiation oncologist Akila Viswanathan, who is the interim director for Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, the director for the National Capital Region for radiation oncology, and a professor of radiation oncology and molecular radiation sciences for Johns Hopkins University School of Medicine.

Dr Akila Viswanathan talks with Dr Jean Wright from Sibley Memorial Hospital about treating breast cancer.

Dr Akila Viswanathan speaks with Dr Curt Deville from Sibley Memorial Hospital in Washington DC about the diagnosis and treatment of prostate cancer and the opening of the Johns Hopkins National Proton Center coming to Sibley later this year.

Dr Rosanne Sheinberg and Harpreet Gujral from the Integrative Medicine Center at Sibley Memorial Hospital provide an introduction to medical cannabis.

Harpreet Gujral talks with Clinical Dietitian Specialist at Sibley Memorial Hospital, Renee Cha, about changes the FDA has mandated for nutrition labels.

Dr Bill Nelson speaks with Dr Karim Boudadi from Sibley Memorial Hospital about the multiple treatment options for HPV related head and neck cancers.

Dr Bill Nelson speaks to neurologic oncologist Dr Byram Ozer about the multi-disciplinary brain cancer program at Sibley Memorial Hospital in Washington DC.

Dr Rosanne Sheinberg and Harpreet Gujral from the Integrative Medicine Center at Sibley Memorial Hospital explain the concept of Forest Bathing and discuss the many benefits of spending more time outside.

Dr Roseanne Sheinberg and Harpreet Gujral speak with Clinical Dietitian Specialist at Sibley Memorial Hospital, Renee Cha, about the importance of nutrition in your short-term and long-term medical outlook.

Today's podcast is going to shed light on the concept of the microbiome and its possible link to the brain and disorders like dementia and Parkinson's. For years we've heard that our diets could possibly be linked to different diseases...but connections between our guts and our brains? How can that be? To help our listeners better understand what the microbiome really is and these possible connections to brain disorders, we have Dr. Aline Charabaty in the studio. Dr. Charabaty is the Director of the Center for Inflammatory Bowel Disease at Sibley Memorial Hospital  - Johns Hopkins School of Medicine in Washington, DC and very knowledgeable on the microbiome. Thank you to the Walter and Jean Boek Global Autoimmune Institute for their ongoing support to make this podcast possible. 

Dr Bill Nelson speaks with Dr Khaled El-Shami about treating leukemia and the growing hematologic program at Sibley Memorial Hospital in Washington DC.

Dr Rosanne Sheinberg and Harpreet Gujral, from the Integrative Medicine Center at Sibley Memorial Hospital, discuss how inflammation and stress can negatively impact your health and offer some advice in combatting them.

Breast cancer is NOT a death sentence; it is serious but there’s plenty of hope. Dr. Maureen O’Donnell (Sullivan Breast Cancer Center, Sibley Memorial Hospital) tells iHeart’s Bernie Lucas about misconceptions, prevention, treatments, recent advances and long-term patient outcomes.

You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world’s leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so the data described here may change as research progresses. Many common cancer treatments can temporarily or permanently affect a woman’s fertility, which is the ability to have children. In today’s podcast, Dr. Karen Lisa Smith shares highlights from her article from the 2018 ASCO Educational Book, “Advances in Fertility Preservation for Young Women With Cancer.” Dr. Smith is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital and assistant professor of oncology at Johns Hopkins University School of Medicine. Published annually, the Educational Book is a collection of articles written by ASCO Annual Meeting speakers and oncology experts. Each volume highlights the most compelling research and developments across the multidisciplinary fields of oncology. ASCO would like to thank Dr. Smith for discussing this topic.  Dr. Smith: Hello, my name is Dr. Karen Lisa Smith from the Johns Hopkins University School of Medicine. In this podcast, I will be sharing some key points from my 2018 ASCO Educational Book article titled, “Advances in Fertility Preservation for Young Women With Cancer.” Each year, over 30,000 young women are diagnosed with cancer in the United States. The most common types of cancers in young women are breast and gynecologic cancers, blood cancers, sarcomas, brain tumors, and colorectal cancer. Many women, especially in Western countries like the United States, are choosing to become pregnant later in life. As a result, young women diagnosed with cancer may not have completed their families at the time of diagnosis. Unfortunately, young women with cancer often require treatments that can make their future chances of childbearing low. For example, chemotherapy is toxic to the ovaries and radiation or surgery on reproductive organs carries a risk of future infertility. Additionally, some long-term treatments, such as hormonal therapy for breast cancer, require a woman to avoid becoming pregnant for years. How to address infertility in cancer survivors is an important clinical issue. The majority of young female cancer survivors report reproductive concerns and many desire children. Pregnancy after cancer treatment does not appear to increase the risk of cancer coming back.  However, young female cancer survivors become pregnant at lower rates than unaffected women in the general population. There is good news for young cancer survivors who wish to start a family. Recent advances in reproductive health care allow doctors to help their patients preserve fertility before cancer treatment begins. Fertility preservation is safe and can often be accomplished without a significant delay in cancer care, especially if fertility goals are addressed early and interested patients are referred to fertility specialists during the course of their cancer treatment planning. There are 2 main types of assisted reproductive the techniques that fertility specialists can use to preserve fertility in young women with cancer. The best established method of fertility preservation is embryo cryopreservation.  Women who use this method first receive hormonal medications for several days to stimulate the ovaries.  Next, they undergo a procedure to remove the eggs from the ovaries.  In the lab, the eggs are fertilized using sperm from a committed male partner or donor sperm.  The embryos are then frozen and stored for future use. Live birth rates using cryopreserved embryos in females with cancer are similar to those in infertile couples who undergo fertility treatments with fresh embryo transfers. For women who do not have a committed male partner or who do not wish to use donor sperm, oocyte cryopreservation has become a standard option for fertility preservation.  This method is similar to embryo cryopreservation in that women receive hormonal medications for several days to stimulate the ovaries and then undergo a procedure to remove the eggs from the ovaries.  However, in the case of oocyte cryopreservation, the eggs are frozen and stored for future use without being fertilized first.  Recent advances in laboratory techniques have allowed for successful oocyte freezing. We only know a little about pregnancy success in patients who freeze their eggs before cancer therapy, but what we do know shows that the success rates are comparable to those seen in the general population of women who freeze eggs in the absence of a cancer diagnosis. A potential benefit of freezing eggs or embryos is the opportunity to test for hereditary conditions. After fertilization and culture, several cells can be sent for genetic analysis to identify known genetic mutations such as a BRCA mutation, which increases the risk for breast and ovarian cancers. Genetic testing may allow couples to avoid passing a known mutation on to their children. Although many cancer survivors may be able to carry a pregnancy after treatment, some survivors will experience late effects of therapy or receive ongoing cancer therapies that make it unsafe or impossible to successfully carry a pregnancy. Cryopreserved embryos or embryos from cryopreserved oocytes may be transferred to a gestational carrier in the future if a patient is unable to carry a pregnancy herself. It is important to note that both embryo cryopreservation and oocyte cryopreservation require women to undergo ovarian stimulation, which helps a woman develop more eggs, followed by egg retrieval. This process takes about 2 to 3 weeks and, therefore, has the potential to briefly delay cancer therapy.  In most cases, this short delay is not significant. Some patients, however, may need to start cancer therapy quickly and cannot wait the 2-3 weeks needed for ovarian stimulation. There are some new techniques currently being investigated for these patients. One method harvests eggs without ovarian stimulation. Patients don’t need to delay treatment with this method and it may have a lower cost. However, implantation and pregnancy success rates with this approach are lower. Another investigational method is ovarian tissue cryopreservation, and this method is the only option for girls who have not yet hit puberty. It results in a minimal delay in treatment and can even be performed after exposure to some chemotherapy. It requires removal of all or part of the ovary, which is then frozen.  The ovarian tissue can then be transplanted back into the patient when she is ready to become pregnant.  Since the first time this technique was used in 2004, there have been over 130 live births reported after ovarian tissue transplantation. As with all procedures, there are risks involved with transplantation, including the possibility of reintroducing cancer cells in this tissue back into the patient. In addition to considering fertility preservation prior to cancer therapy using the assisted reproductive techniques we have reviewed so far, young women with cancer can talk to their oncologists about ovarian suppression during chemotherapy as a method for ovarian protection and fertility preservation.  Mediations called gonadotropin releasing hormone agonists (or GnRH agonists), help to reduce the toxicity of chemotherapy on the ovaries, and some studies have shown that this decreases the risk of infertility after cancer treatment. This treatment can also reduce the risk of early menopause resulting from chemotherapy. Although many young women with cancer report desiring children and options for fertility preservation are available, few young women pursue these options. For example, in 1 study of 1,041 young women with cancer, only 4% pursued fertility preservation. There are many reasons for this, but young women who are diagnosed with cancer and wish to start or grow their family should talk to their doctors about their fertility preservation options before starting treatment. To learn more, please view my article online at ASCO.org/edbook. Thank you. ASCO: Thank you Dr. Smith. Please visit ASCO.org/edbook to read the full article. And if this podcast was useful, please take a minute to subscribe, rate, and review the show on Apple Podcasts or Google Play. Cancer.Net is supported by ASCO’s Conquer Cancer Foundation, which funds breakthrough research for every type of cancer, helping patients everywhere. To help fund Cancer.Net and programs like it, donate at conquer.org/support.  

Hear Dr. Sam Harrington as we discuss his book, At Peace: Choosing a Good Death After a Long Life. Does dying in the hospital hooked up to tubes scare you? What about your parents? How do you have the conversation? When do you decide that a caring choice is the decision to avoid repeated hospitalizations and over testing? You have choices you might not think you have. There are some things that will directly lead you down the path of hospitalization and then death. My guest, Dr. Samuel Harrington is an honors graduate of Harvard College and the University of Wisconsin Medical School. He practiced internal medicine and gastroenterology for more than 30 years in Washington, D.C. There he served on the board of trustees of Sibley Memorial Hospital, a member of the Johns Hopkins Health System, and the former Hospice Care of DC. As the American health care system evolved around him, becoming increasingly complex and increasingly commercialized, Sam became interested in end-of-life issues. We are going to talk about all these things and his book, At Peace, Choosing a Good Death After a Long Life.

How do we give our carees (and ourselves) peace at end of life? Dr. Samuel Harrington, author of a new book, At Peace: Choosing a Good Death After a Long Life, joins us to guide us toward a peaceful end. Most people say they would like to die quietly at home. But overly aggressive medical advice, coupled with an unrealistic sense of invincibility, results in the majority of elderly patients misguidedly dying in institutions while undergoing painful procedures, instead of having a better and more peaceful death they desired. AT PEACE outlines specific active and passive steps that older patients and their health care proxies can take to insure loved ones pass their last days comfortably at home and/or in hospice, when further aggressive care is inappropriate. Through Dr. Harrington's own experience with his parents and patients, he describes the terminal patterns of the six most common chronic diseases; how to recognize a terminal diagnosis even when the doctor is not clear about it; how to have the hard conversation about end-of-life wishes; how to minimize painful treatments and when to seek hospice care. The current estimated U.S. senior population 65 and older is well over fifty million strong. AT PEACE is a relevant and necessary resource for families across the board. Samuel Harrington, MD, a graduate of Harvard College and the University of Wisconsin Medical School, concentrated his practice at Sibley Memorial Hospital. His work as Sibley's patient safety officer representative to the Johns Hopkins Medicine Board of Trustees and his service on the board of a nonprofit hospice in Washington D.C. informed his passion for helping aged patients make appropriate end-of-life decisions. --- Send in a voice message: https://anchor.fm/caring-conversations/message

How do we give our carees (and ourselves) peace at end of life? Dr. Samuel Harrington, author of a new book, At Peace: Choosing a Good Death After a Long Life, joins us to guide us toward a peaceful end. Most people say they would like to die quietly at home. But overly aggressive medical advice, coupled with an unrealistic sense of invincibility, results in the majority of elderly patients misguidedly dying in institutions while undergoing painful procedures, instead of having a better and more peaceful death they desired. AT PEACE outlines specific active and passive steps that older patients and their health care proxies can take to insure loved ones pass their last days comfortably at home and/or in hospice, when further aggressive care is inappropriate. Through Dr. Harrington's own experience with his parents and patients, he describes the terminal patterns of the six most common chronic diseases; how to recognize a terminal diagnosis even when the doctor is not clear about it; how to have the hard conversation about end-of-life wishes; how to minimize painful treatments and when to seek hospice care. The current estimated U.S. senior population 65 and older is well over fifty million strong. AT PEACE is a relevant and necessary resource for families across the board. Samuel Harrington, MD, a graduate of Harvard College and the University of Wisconsin Medical School, concentrated his practice at Sibley Memorial Hospital. His work as Sibley's patient safety officer representative to the Johns Hopkins Medicine Board of Trustees and his service on the board of a nonprofit hospice in Washington D.C. informed his passion for helping aged patients make appropriate end-of-life decisions. --- Send in a voice message: https://anchor.fm/caring-conversations/message

Dr. Samuel Harrington, MD, is the author of At Peace: Choosing a Good Death After a Long Life. In this important book, which James Fallows of The Atlantic calls “deeply humane,”  he argues the case for taking a clear-eyed yet compassionate view towards the end of life. Most people say they would like to die quietly at home. But overly aggressive medical advice, coupled with an unrealistic sense of invincibility, results in the majority of elderly patients misguidedly dying in institutions while undergoing painful procedures, instead of having a better and more peaceful death they desired.  Dr. Harrington is a graduate of Harvard College and the University of Wisconsin Medical School. Professionally, he concentrated his practice at Sibley Memorial Hospital also served on the board of a nonprofit hospice in Washington, D.C. He also listened to his parents when they were facing end of life decisions and helped them enter this period of their lives peacefully, while being able to live at home. It was these two experiences together that prompted his desire to write this book. AT PEACE outlines specific active and passive steps that older patients and their health care proxies can take to insure loved ones pass their last days comfortably at home and/or in hospice, when further aggressive care is inappropriate.

At Peace with Dr. Sam HarringtonDr. Samuel Harrington, MD, is the author of At Peace: Choosing a Good Death After a Long Life. In this important book, which James Fallows of The Atlantic calls “deeply humane,” he argues the case for taking a clear-eyed yet compassionate view towards the end of life. Dr. Harrington is a graduate of Harvard College and the University of Wisconsin Medical School. Professionally, he concentrated his practice at Sibley Memorial Hospital also served on the board of a nonprofit hospice in Washington, D.C. https://samharrington.com

Dr. Benjamin Levy, Clinical Director at the Johns Hopkins Sidney Kimmel Cancer Center at the Sibley Memorial Hospital in Washington, D.C., presents a self-evaluation questions on non-small cell lung cancer.

Kelli Jennings is a Registered Dietitian who describes herself as someone with a passion for healthy eating, wellness, & sports nutrition. She is an avid athlete herself, and has become a leader and expert in the field of Sports Nutrition for endurance athletes. Her journey started with graduating from the University of Northern Colorado with a degree in Dietetics, earning a residency at Sibley Memorial Hospital in Washington, DC, and accepting a position from George Washington University Hospital as a clinical dietitian specializing in cardiac disease, neurology, neonates, and diabetes. From there, she began a private practice to focus on preventative nutrition, wellness and endurance sports. The website for Kelli's services is http://www.apexnutritionllc.com/fuelrightblog/. On Titter Kelli resides at @fuelright. Since I don't do Facebook, https://www.facebook.com/pages/Apex-Nutrition-LLC/210530685641458. Kelli joins us to discuss the importance of hydration, specifically in short distance time trial events.